NO752762L - - Google Patents
Info
- Publication number
- NO752762L NO752762L NO752762A NO752762A NO752762L NO 752762 L NO752762 L NO 752762L NO 752762 A NO752762 A NO 752762A NO 752762 A NO752762 A NO 752762A NO 752762 L NO752762 L NO 752762L
- Authority
- NO
- Norway
- Prior art keywords
- chlorophenoxy
- ester
- reaction
- nicotinoyl
- dimethylformamide
- Prior art date
Links
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 45
- 238000006243 chemical reaction Methods 0.000 claims description 24
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 21
- -1 glycol ester Chemical class 0.000 claims description 20
- 238000000034 method Methods 0.000 claims description 18
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 16
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims description 16
- 239000011664 nicotinic acid Substances 0.000 claims description 12
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 11
- 238000004519 manufacturing process Methods 0.000 claims description 8
- 238000009835 boiling Methods 0.000 claims description 7
- 229960003512 nicotinic acid Drugs 0.000 claims description 5
- 235000001968 nicotinic acid Nutrition 0.000 claims description 5
- 150000001447 alkali salts Chemical class 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 4
- 238000002425 crystallisation Methods 0.000 claims description 3
- 230000008025 crystallization Effects 0.000 claims description 3
- 238000004821 distillation Methods 0.000 claims description 3
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 3
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 230000007306 turnover Effects 0.000 claims 1
- 150000002148 esters Chemical class 0.000 description 7
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- 239000007844 bleaching agent Substances 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 239000007903 gelatin capsule Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- SZIFAVKTNFCBPC-UHFFFAOYSA-N 2-chloroethanol Chemical compound OCCCl SZIFAVKTNFCBPC-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 150000001348 alkyl chlorides Chemical class 0.000 description 2
- DLGYNVMUCSTYDQ-UHFFFAOYSA-N azane;pyridine Chemical compound N.C1=CC=NC=C1 DLGYNVMUCSTYDQ-UHFFFAOYSA-N 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- TXCGAZHTZHNUAI-UHFFFAOYSA-N clofibric acid Chemical compound OC(=O)C(C)(C)OC1=CC=C(Cl)C=C1 TXCGAZHTZHNUAI-UHFFFAOYSA-N 0.000 description 2
- 239000008298 dragée Substances 0.000 description 2
- 239000012065 filter cake Substances 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 235000021588 free fatty acids Nutrition 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 239000012452 mother liquor Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- ATBIAJXSKNPHEI-UHFFFAOYSA-N pyridine-3-carbonyl chloride Chemical compound ClC(=O)C1=CC=CN=C1 ATBIAJXSKNPHEI-UHFFFAOYSA-N 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 2
- CLWAXFZCVYJLLM-UHFFFAOYSA-N 1-chlorohexadecane Chemical compound CCCCCCCCCCCCCCCCCl CLWAXFZCVYJLLM-UHFFFAOYSA-N 0.000 description 1
- CEJKAKCQVUWNNA-UHFFFAOYSA-N 2-(4-chlorophenoxy)butanoic acid Chemical compound CCC(C(O)=O)OC1=CC=C(Cl)C=C1 CEJKAKCQVUWNNA-UHFFFAOYSA-N 0.000 description 1
- IUAXUYMFMHJWHL-UHFFFAOYSA-N 2-chloroethyl 2-(4-chlorophenoxy)-2-methylpropanoate Chemical compound ClCCOC(=O)C(C)(C)OC1=CC=C(Cl)C=C1 IUAXUYMFMHJWHL-UHFFFAOYSA-N 0.000 description 1
- 229910015900 BF3 Inorganic materials 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 206010014476 Elevated cholesterol Diseases 0.000 description 1
- 206010014486 Elevated triglycerides Diseases 0.000 description 1
- 208000035150 Hypercholesterolemia Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000029936 alkylation Effects 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000000571 coke Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 235000019439 ethyl acetate Nutrition 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229940126601 medicinal product Drugs 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 210000002741 palatine tonsil Anatomy 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 150000003222 pyridines Chemical class 0.000 description 1
- 238000005956 quaternization reaction Methods 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000005292 vacuum distillation Methods 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB3877874A GB1442474A (en) | 1974-09-05 | 1974-09-05 | Process for the production of beta-2-p-chlorophenoxy-isobutyryloxy -ethyl nicotinate |
Publications (1)
Publication Number | Publication Date |
---|---|
NO752762L true NO752762L (zh) | 1976-03-08 |
Family
ID=10405641
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO752762A NO752762L (zh) | 1974-09-05 | 1975-08-06 |
Country Status (17)
Country | Link |
---|---|
JP (1) | JPS597702B2 (zh) |
AR (1) | AR205658A1 (zh) |
AT (1) | AT344173B (zh) |
BE (1) | BE832618R (zh) |
CA (1) | CA1054153A (zh) |
CH (1) | CH584198A5 (zh) |
DE (1) | DE2531254A1 (zh) |
DK (1) | DK145929C (zh) |
ES (1) | ES440711A1 (zh) |
FI (1) | FI60392C (zh) |
FR (1) | FR2283892A2 (zh) |
GB (1) | GB1442474A (zh) |
HU (1) | HU169891B (zh) |
NL (1) | NL7510526A (zh) |
NO (1) | NO752762L (zh) |
PL (1) | PL97697B1 (zh) |
YU (1) | YU37132B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4375545A (en) * | 1981-06-22 | 1983-03-01 | Westwood Pharmaceuticals, Inc. | Process for the synthesis of the nicotinyl ester of 6-aminonicotinic acid |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2304405A1 (de) * | 1972-03-08 | 1973-09-13 | Hurka Wilhelm | Ester der p-chlorphenoxyisobuttersaeure und verfahren zu deren herstellung |
-
1974
- 1974-09-05 GB GB3877874A patent/GB1442474A/en not_active Expired
-
1975
- 1975-01-01 AR AR260267A patent/AR205658A1/es active
- 1975-07-12 DE DE19752531254 patent/DE2531254A1/de not_active Withdrawn
- 1975-07-18 FI FI752079A patent/FI60392C/fi not_active IP Right Cessation
- 1975-07-28 YU YU1923/75A patent/YU37132B/xx unknown
- 1975-07-30 AT AT591475A patent/AT344173B/de not_active IP Right Cessation
- 1975-08-06 NO NO752762A patent/NO752762L/no unknown
- 1975-08-21 BE BE159356A patent/BE832618R/xx active
- 1975-08-25 CA CA234,142A patent/CA1054153A/en not_active Expired
- 1975-08-29 DK DK390875A patent/DK145929C/da not_active IP Right Cessation
- 1975-08-30 JP JP50105573A patent/JPS597702B2/ja not_active Expired
- 1975-09-04 HU HUME1893A patent/HU169891B/hu not_active IP Right Cessation
- 1975-09-04 ES ES440711A patent/ES440711A1/es not_active Expired
- 1975-09-05 FR FR7527367A patent/FR2283892A2/fr active Granted
- 1975-09-05 CH CH1151575A patent/CH584198A5/xx not_active IP Right Cessation
- 1975-09-05 NL NL7510526A patent/NL7510526A/xx unknown
- 1975-09-05 PL PL1975183136A patent/PL97697B1/pl unknown
Also Published As
Publication number | Publication date |
---|---|
FI60392B (fi) | 1981-09-30 |
CA1054153A (en) | 1979-05-08 |
FI60392C (fi) | 1982-01-11 |
JPS597702B2 (ja) | 1984-02-20 |
FI752079A (zh) | 1976-03-06 |
FR2283892A2 (fr) | 1976-04-02 |
DK145929C (da) | 1983-09-26 |
DK145929B (da) | 1983-04-18 |
NL7510526A (nl) | 1976-03-09 |
BE832618R (fr) | 1975-12-16 |
ATA591475A (de) | 1977-11-15 |
DE2531254A1 (de) | 1976-03-25 |
PL97697B1 (pl) | 1978-03-30 |
CH584198A5 (zh) | 1977-01-31 |
YU192375A (en) | 1983-04-27 |
ES440711A1 (es) | 1977-03-16 |
YU37132B (en) | 1984-08-31 |
GB1442474A (en) | 1976-07-14 |
AT344173B (de) | 1978-07-10 |
FR2283892B2 (zh) | 1980-08-08 |
DK390875A (da) | 1976-03-06 |
JPS5168572A (en) | 1976-06-14 |
AR205658A1 (es) | 1976-05-21 |
HU169891B (zh) | 1977-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE2155483A1 (de) | Pyridinderivate | |
DK158980B (da) | Analogifremgangsmaade til fremstilling af 2,5-bis-(2,2,2-trifluorethoxy)-n-(2-piperidylmethyl)benzamid eller et farmaceutisk acceptabelt syreadditionssalt deraf | |
CH645625A5 (de) | Benzoesaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel. | |
DE2609962A1 (de) | Para- eckige klammer auf aryl (alkyl- oder alkenyl)amino eckige klammer zu benzoesaeurederivate und verfahren zu ihrer herstellung | |
US4988708A (en) | Analgesic and anti-inflammatory 4-OH quinoline carboxylic acid derivatives | |
US3332942A (en) | Substituted thiadiazoles | |
CH640212A5 (en) | Process for the preparation of 1-amino-3-aryloxy-2-propanol derivatives | |
NO752762L (zh) | ||
Levene et al. | The action of acetic anhydride and pyridine on amino acids | |
CH472407A (de) | Verfahren zur Herstellung neuer 2-Benzyl-1,3,4,9b-tetrahydro-2H-indeno(1,2-c)pyridin-Derivate | |
NO803693L (no) | 2,3-indoldion-derivater. | |
NO151387B (no) | Innstillingsinnretning for en elektronisk digitalindikator | |
DE2337126C3 (de) | Iminodibenzyl-Derivate und Verfahren zu deren Herstellung | |
US2906757A (en) | Their preparation | |
EP0295218B1 (en) | A process for the preparation of 2,4-diamino-6-(1-piperidinyl)-pyrimidine n-oxide | |
US4051143A (en) | Process for the production of α-[2-(p-chlorophenoxy)-isobutyryl]-β-nicotinoyl glycol ester | |
US2695902A (en) | 2-methyl-3-(beta-chloroethyl)-4, 6-dichloro pyridine and method of making same | |
IE41462B1 (en) | Piperidyl-methylenedioxybenzene derivatives | |
US2740781A (en) | 3, 26-dihydroxy-16, 22-imino-5-cholestenes, 3, 26-dihydroxy-16, 22-imino-5, 16, 20(22)-cholestatrienes and derivatives thereof | |
KR790001360B1 (ko) | α-[2-(P-클로로페녹시)-이소부티릴]-β-니코티노일 글리콜 에스테르의 제조방법 | |
KR880001715B1 (ko) | 1-푸릴-3,4-디하이드로이소퀴놀린의 제조방법 | |
NO823213L (no) | Fremgangsmaate for fremstilling av antranilsyreestere | |
US5380856A (en) | Process for preparation of a polymorphic form of terphenadine having a high melting point and enhanced purity, and the product thus obtained | |
SU858565A3 (ru) | Способ получени производных 1,3-пергидротиазина | |
DE2348951A1 (de) | Octahydroisochinoline, ihre salze, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |